Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Bibliographic Details
Main Authors:	Forbes, John F, Sestak, Ivana, Howell, Anthony, Bonanni, Bernardo, Bundred, Nigel, Levy, Christelle, von Minckwitz, Gunter, Eiermann, Wolfgang, Neven, Patrick, Stierer, Michael, Holcombe, Chris, Coleman, Robert E, Jones, Louise, Ellis, Ian, Cuzick, Jack
Format:	Online
Language:	English
Published:	Elsevier 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769326/

id	pubmed-4769326
recordtype	oai_dc
spelling	pubmed-47693262016-03-11 Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial Forbes, John F Sestak, Ivana Howell, Anthony Bonanni, Bernardo Bundred, Nigel Levy, Christelle von Minckwitz, Gunter Eiermann, Wolfgang Neven, Patrick Stierer, Michael Holcombe, Chris Coleman, Robert E Jones, Louise Ellis, Ian Cuzick, Jack Articles Elsevier 2016-02-27 /pmc/articles/PMC4769326/ /pubmed/26686313 http://dx.doi.org/10.1016/S0140-6736(15)01129-0 Text en © 2016 Forbes et al. Open Access article distributed under the terms of CC BY http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Forbes, John F Sestak, Ivana Howell, Anthony Bonanni, Bernardo Bundred, Nigel Levy, Christelle von Minckwitz, Gunter Eiermann, Wolfgang Neven, Patrick Stierer, Michael Holcombe, Chris Coleman, Robert E Jones, Louise Ellis, Ian Cuzick, Jack
spellingShingle	Forbes, John F Sestak, Ivana Howell, Anthony Bonanni, Bernardo Bundred, Nigel Levy, Christelle von Minckwitz, Gunter Eiermann, Wolfgang Neven, Patrick Stierer, Michael Holcombe, Chris Coleman, Robert E Jones, Louise Ellis, Ian Cuzick, Jack Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
author_facet	Forbes, John F Sestak, Ivana Howell, Anthony Bonanni, Bernardo Bundred, Nigel Levy, Christelle von Minckwitz, Gunter Eiermann, Wolfgang Neven, Patrick Stierer, Michael Holcombe, Chris Coleman, Robert E Jones, Louise Ellis, Ian Cuzick, Jack
author_sort	Forbes, John F
title	Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
title_short	Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
title_full	Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
title_fullStr	Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
title_full_unstemmed	Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
title_sort	anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (ibis-ii dcis): a double-blind, randomised controlled trial
description
publisher	Elsevier
publishDate	2016
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769326/
_version_	1613544065930887168

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Similar Items